{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:45:42Z","timestamp":1771008342851,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.cca.2013.11.007","type":"journal-article","created":{"date-parts":[[2013,11,21]],"date-time":"2013-11-21T01:47:09Z","timestamp":1384998429000},"page":"77-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: A crucial role for the CYP2B6*6 allele"],"prefix":"10.1016","volume":"428","author":[{"given":"In Cheol","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Yup","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung Kon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heuy Sun","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Dong","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.11.007_bb0005","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","article-title":"The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction","volume":"23","author":"Hansen","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl. 2","key":"10.1016\/j.cca.2013.11.007_bb0010","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2014the evidence report","volume":"6","author":"National Institutes of Health","year":"1998","journal-title":"Obes Res"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2013.11.007_bb0015","first-page":"S18","article-title":"Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine","volume":"22","author":"Heal","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.cca.2013.11.007_bb0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0028-3908(89)90048-8","article-title":"The contribution of metabolites to the rapid and potent down-regulation of rat cortical beta-adrenoceptors by the putative antidepressant sibutramine hydrochloride","volume":"28","author":"Luscombe","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cca.2013.11.007_bb0025","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2165\/00003495-199856060-00019","article-title":"Sibutramine. A review of its contribution to the management of obesity","volume":"56","author":"McNeely","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.cca.2013.11.007_bb0030","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1124\/dmd.108.020727","article-title":"Cytochrome P450 2B6 catalyzes the formation of pharmacologically active sibutramine (N-{1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}-N, N-dimethylamine) metabolites in human liver microsomes","volume":"36","author":"Bae","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.cca.2013.11.007_bb0035","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects","volume":"116","author":"Ingelman-Sundberg","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.cca.2013.11.007_bb0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0091270010362906","article-title":"Effect of CYP2B6 genotype on the pharmacokinetics of sibutramine and active metabolites in healthy subjects","volume":"51","author":"Chung","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.cca.2013.11.007_bb0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/clpt.2009.145","article-title":"Association of CYP2B6, CYP3A5, and CYP2C19 genetic polymorphisms with sibutramine pharmacokinetics in healthy Korean subjects","volume":"86","author":"Kim","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cca.2013.11.007_bb0050","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/sj.tpj.6500462","article-title":"The clinical role of genetic polymorphisms in drug-metabolizing enzymes","volume":"8","author":"Tomalik-Scharte","year":"2008","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.cca.2013.11.007_bb0055","series-title":"The LEARN manual for weight management","author":"Brownell","year":"2004"},{"key":"10.1016\/j.cca.2013.11.007_bb0060","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/dc12-0733","article-title":"Pretreatment, psychological, and behavioral predictors of weight outcomes among lifestyle intervention participants in the Diabetes Prevention Program (DPP)","volume":"36","author":"Delahanty","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2013.11.007_bb0065","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10875-007-9095-x","article-title":"Genetic polymorphisms of LMP\/TAP gene and hepatitis B virus infection risk in the Chinese population","volume":"27","author":"Xu","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cca.2013.11.007_bb0070","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2013.11.007_bb0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group","volume":"352","author":"Sjostrom","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2013.11.007_bb0080","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.eurpsy.2009.12.007","article-title":"Effect of catechol-O-methyltransferase Val(108\/158)Met polymorphism on antidepressant efficacy of fluvoxamine","volume":"25","author":"Benedetti","year":"2010","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.cca.2013.11.007_bb0085","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.clpt.2005.02.010","article-title":"Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation","volume":"77","author":"Turpeinen","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cca.2013.11.007_bb0090","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1177\/0091270010388651","article-title":"Effects of clopidogrel on the pharmacokinetics of sibutramine and its active metabolites","volume":"51","author":"Bae","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.cca.2013.11.007_bb0095","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa1003114","article-title":"Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects","volume":"363","author":"James","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2013.11.007_bb0100","series-title":"Coronary heart disease epidemiology: from aetiology to public health","author":"Marmot","year":"2005"},{"key":"10.1016\/j.cca.2013.11.007_bb0105","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.clpt.2006.02.002","article-title":"Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects","volume":"79","author":"Heusser","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.cca.2013.11.007_bb0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.ijo.0800540","article-title":"Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study","volume":"22","author":"Hanotin","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.cca.2013.11.007_bb0115","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1067\/mhj.2002.124403","article-title":"Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction","volume":"144","author":"Zannad","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.cca.2013.11.007_bb0120","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/sj.ijo.0802887","article-title":"Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials","volume":"29","author":"Jordan","year":"2005","journal-title":"Int J Obes"},{"key":"10.1016\/j.cca.2013.11.007_bb0125","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/eurheartj\/ehl259","article-title":"High heart rate: a cardiovascular risk factor?","volume":"27","author":"Cook","year":"2006","journal-title":"Eur Heart J"},{"issue":"Suppl. 1","key":"10.1016\/j.cca.2013.11.007_bb0130","first-page":"S25","article-title":"Sibutramine: a review of the pharmacology of a novel anti-obesity agent","volume":"21","author":"Stock","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.cca.2013.11.007_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-008-9914-2","article-title":"Effect of sibutramine HCl on cardiac hERG K+ channel","volume":"320","author":"Kim","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.cca.2013.11.007_bb0140","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.107.133306","article-title":"Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver","volume":"325","author":"Hofmann","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cca.2013.11.007_bb0145","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2217\/14622416.8.7.743","article-title":"Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance","volume":"8","author":"Zanger","year":"2007","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.cca.2013.11.007_bb0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.pharmtox.48.113006.094753","article-title":"Pharmacogenetics of anti-HIV drugs","volume":"48","author":"Telenti","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.cca.2013.11.007_bb0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","article-title":"Role of CYP2B6 in stereoselective human methadone metabolism","volume":"108","author":"Totah","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cca.2013.11.007_bb0160","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1463-1326.2007.00740.x","article-title":"Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success","volume":"10","author":"Elfhag","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cca.2013.11.007_bb0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.physbeh.2003.07.010","article-title":"Effect of sibutramine on macronutrient selection in male and female rats","volume":"80","author":"LeBlanc","year":"2003","journal-title":"Physiol Behav"},{"key":"10.1016\/j.cca.2013.11.007_bb0170","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.physbeh.2005.10.014","article-title":"Effects of sibutramine on the appetitive and consummatory aspects of feeding in non-human primates","volume":"87","author":"Foltin","year":"2006","journal-title":"Physiol Behav"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113004452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898113004452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T17:47:04Z","timestamp":1564854424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898113004452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":34,"alternative-id":["S0009898113004452"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.11.007","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of CYP3A5, CYP2C19, and CYP2B6 on the clinical efficacy and adverse outcomes of sibutramine therapy: A crucial role for the CYP2B6*6 allele","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}